Epidemiology: Social Anxiety Disorder – Highly co-morbid anxiety disorder will continue to remain a significant public health burden

In 2011, Datamonitor estimates that there were approximately 19.098 million men and women with SAD in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK), and more than three quarters of these cases (79%) were found in the US alone.
Features and benefits

• Gain insight into market potential, including a robust 10-year epidemiology forecast of social anxiety disorder prevalent cases.
• Understand the key epidemiologic risk factors and co-morbidities associated with SAD.

Highlights
Datamonitor estimates that the prevalence of SAD in the seven major markets is highest among US adults aged 20–29 years and also 30–39 years; both age groups are projected to have a significant increase in the number of prevalent cases during the forecast period, according to Datamonitor forecasts.
Prevalent cases of SAD in adults aged 20–29 and 30–39 years in the five major EU markets (France, Germany, Italy, Spain, and the UK) and Japan will remain relatively stable throughout the forecast period.
Your key questions answered

• What are the most robust sources for social anxiety disorder prevalence data?
• How will the patient population change over the next decade in the seven major markets?
• What are the major co-morbid conditions with SAD that contribute to the severity of the disorder?
• How will the proposed changes to the current SAD diagnostic criteria affect the total prevalence of SAD near the end of the forecast period?

Buy your copy of this report @ http://www.reportsnreports.com/reports/182229-epidemiology-social-anxiety-disorder-highly-co-morbid-anxiety-disorder-will-continue-to-remain-a-significant-public-health-burden.html

Report Details:

Published: July 2012

No. of Pages: 42

Price: Single User License – US$5700             Corporate User License – US$14250

                                                   

Table of Contents
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Key findings
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Diagnostic criteria
Diagnostic tools
GLOBAL VARIATION AND HISTORICAL TRENDS
Global variation
Historical trends
DRIVERS OF SOCIAL ANXIETY DISORDER EPIDEMIOLOGY
Although SAD onset is typically in early adolescence, clinical diagnosis may be up to a decade after disease onset
Like other anxiety disorders, SAD is typically more prevalent in women than men
SAD is highly co-morbid with other psychiatric disorders
Up to 20% of people with an eating disorder also have SAD
Drug and alcohol dependence are common among those with SAD
Familial environmental factors affect SAD development
Family history may increase risk of SAD threefold
EPIDEMIOLOGIC FORECASTING OF SOCIAL ANXIETY DISORDER
Subpopulations
Age and gender
US
Sources used
Methods
Sources not used
Japan
Sources used
Methods
Sources not used
France
Sources used
Methods
Sources not used
Germany
Sources used
Methods
Italy
Sources used
Methods
Sources not used
Spain
Sources used
Methods
Sources not used
UK
Sources used
Methods
EPIDEMIOLOGIC RESULTS
Current prevalent cases and future trends
Average annual growth rate of social anxiety disorder total prevalence
Age-standardized results for prevalent cases of social anxiety disorder
Subpopulations for prevalent cases of social anxiety disorder
In 2011, over 46% of all prevalent cases of social anxiety disorder occurred in adults under the age of 40 in the seven major markets
DISCUSSION
Limitations of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
List of Tables
Table: Common fears in social anxiety disorder
Table: Diagnostic criteria for social anxiety disorder; comparing DSM-IV and ICD-10
Table: Clinical dimensions of social anxiety disorder
Table: Alternative social anxiety disorder diagnostic tools
Table: Comparison of social anxiety disorder and taijin kyofusho
Table: Population -based studies of total social anxiety disorder 12-month prevalence used in this forecast
Table: Total prevalent cases of social anxiety disorder in adults over the age of 20 in the seven major markets (millions), 2011–21
Table: Total prevalent cases of social anxiety disorder in each of the seven major markets in adults aged 20 and over, by age group (millions), 2011
Table: Total prevalent cases of social anxiety disorder in the seven major markets in adults aged 20 and over, by sex (millions), 2011
Table: Proposed DSM-V social anxiety disorder criteria changes (and rationale), which may affect prevalence rates in the seven major markets
List of Figures
Figure: Total prevalent cases of social anxiety disorder in adults over the age of 20 in the seven major markets (millions), 2011–21
Figure: Average annual growth rate in total prevalent social anxiety disorder cases across the seven major markets (%), 2011–21
Figure: Age-standardized prevalence of social anxiety disorder in both genders in the seven major markets, 2011

For more details Contact:   sales@reportsandreports.com